Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03427983 · ClinicalTrials.gov registry record · NA
Hydrodissection as a Treatment for Carpal Tunnel Syndrome
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03427983: Completed NA study, sponsored by Mayo Clinic.
NCT03427983 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03427983, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a pilot study designed to acquire data on the added value of hydrodissection when using a corticosteroid injection as a treatment for patients with carpal tunnel syndrome. Hydrodissection is part of a standard clinical care injection under ultrasound guidance in which the fluid is used to separate the nerve from surrounding structures.
Interventions
- PROCEDURE Hydrodissection
- PROCEDURE Regular Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03427983
The ClinicalTrials.gov registry entry for NCT03427983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrodissection is the first listed.
NCT03427983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03427983 about?
NCT03427983 is a clinical study titled "Hydrodissection as a Treatment for Carpal Tunnel Syndrome". This is a pilot study designed to acquire data on the added value of hydrodissection when using a corticosteroid injection as a treatment for patients with carpal tunnel syndrome. Hydrodissection is part of a standard clinical care injection under ultrasound guidance in which the fluid is used to se...
What is the current status of trial NCT03427983?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-03-08. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03427983?
The interventions under investigation include: Hydrodissection (PROCEDURE), Regular Injection (PROCEDURE).
Who is sponsoring clinical trial NCT03427983?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.